02006nam a2200397 i 4500001001300000003000300013005001700016007001400033008004100047040002500088041000800113042000800121043001200129050002000141074001600161086002900177110010200206245021900308264006000527264010100587300002800688336002600716337002700742338003100769490002300800500003600823500002500859504004100884533010600925650004001031650005901071655003301130776020101163776018401364810006001548ocn954068048BD20161013074337.0he bmb024bbca160727s2016    dcu     bb   f000 0 eng c  aPUCPRbengerdacGPO  aspa  apcc  an-us---14aKF26b.L27 2013  a1043-B (MF)0 aY 4.L 11/4:S.HRG.113-7561 aUnited States.bCongress.bSenate.bCommittee on Health, Education, Labor, and Pensions,eauthor.10aPharmaceutical compounding: proposed legislative solution :bhearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, first session ... May 9, 2013. 1aWashington :bU.S. Government Publishing Office,c2016. 2aWashington, DC :bFor sale by the Superintendent of Documents, U.S. Government Publishing Office  aiii, 60 pages ;c24 cm.  atextbtxt2rdacontent  amicroformbh2rdamedia  amicrofichebhe2rdacarrier1 aS. hrg. ;v113-756  aShipping list no.: 2016-0157-M.  aCRDP Project record.  aIncludes bibliographical references.  aMicrofiche.b[Washington, D.C.] :cU.S. Government Printing Office,d[2016]e1 microfiche : negative. 0aDrugsxDosage formszUnited States. 0aDrug adulterationxLaw and legislationzUnited States. 7aLegislative hearings.2lcgft08iPrint version:aUnited States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.tPharmaceutical compounding: proposed legislative solutionw(DLC) 2015464810w(OCoLC)94596948908iOnline version:aUnited States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.tPharmaceutical compounding: proposed legislative solutionw(OCoLC)9459237311 aUnited States.bCongress.bSenate.tS. hrg. ;v113-756.